SCHEMBL194822

SCHEMBL194822

O=Cc1ccno1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL356230 0.74
SCHEMBL2360119 0.72
SCHEMBL5704609 0.70
SCHEMBL15765095 0.69 HCAR2 (0.48)
SCHEMBL26932947 0.68 TAAR1 (0.34)
SCHEMBL27390227 0.68 HCAR2 (0.32)
SCHEMBL51391 0.67
SCHEMBL2310170 0.67 TAAR1 (0.33)
SCHEMBL9113080 0.66
SCHEMBL28565958 0.65 ALDH1A1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 435 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108250157-B Method for synthesizing N- [2- (2-arylbenzothiazole) ] -amide under catalysis of rhodium 江西师范大学 2021-12-21 CN claimed
CN-111100092-A Method for direct amination of thioamide-oriented aromatic hydrocarbon carbon-hydrogen 宁夏大学 2020-05-05 CN claimed
CN-107108600-A It is used as the heteroarylalkylenyl aryl sultam derivative of RORc conditioning agents 豪夫迈·罗氏有限公司 2017-08-29 CN claimed
CN-103539753-B A kind of synthetic method of the isoxazole carboxylic acid of 3 substitution 4 上海药明康德新药开发有限公司 2017-06-23 CN claimed
US-8367719-B2 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase JANSSEN PHARMACEUTICA NV (BE) 2013-02-05 US claimed
CN-102812011-A [1,5] -diazacyclo-octatetraene derivative MELLITECH 2012-12-05 CN claimed
EP-2501685-A1 [1,5]-DIAZOCIN DERIVATIVES Mellitech (FR) 2012-09-26 EP claimed
US-20120225892-A1 [1,5]-Diazocin Derivatives MELLITECH (FR) 2012-09-06 US claimed
EP-1817036-B1 MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMA (US) 2012-07-04 EP claimed
US-20110263639-A1 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase Janseen Pharmaceutical NV 2011-10-27 US claimed
CN-1072222-C Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings UPJOHN CO (US) 2001-10-03 CN claimed
US-6166056-A Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings PHARMACIA (US) 2000-12-26 US claimed
US-5922707-A Oxazolidinone antibacterial agent with tricyclic substituents PHARMACIA & UPJOHN COMPANY (US) 1999-07-13 US claimed
EP-0874852-A1 OXAZOLIDINONE ANTIBACTERIAL AGENT WITH TRICYCLIC SUBSTITUENTS PHARMACIA &amp; UPJOHN COMPANY (US) 1998-11-04 EP claimed
CN-1197457-A Phenyloxazolidinones having a C-C bond to a 4-8 membered heterocyclic ring UPJOHN CO (US) 1998-10-28 CN claimed
EP-0856002-A1 PHENYLOXAZOLIDINONES HAVING A C-C BOND TO 4-8 MEMBERED HETEROCYCLIC RINGS PHARMACIA &amp; UPJOHN COMPANY (US) 1998-08-05 EP claimed
WO-1997019089-A1 OXAZOLIDINONE ANTIBACTERIAL AGENT WITH TRICYCLIC SUBSTITUENTS PHARMACIA & UPJOHN COMPANY (US) 1997-05-29 WO claimed
WO-1997009328-A1 PHENYLOXAZOLIDINONES HAVING A C-C BOND TO 4-8 MEMBERED HETEROCYCLIC RINGS PHARMACIA & UPJOHN COMPANY (US) 1997-03-13 WO claimed
US-5017212-A For rice paddies TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-05-21 US claimed
EP-0302491-A1 5-Formyl-isoxazoles BASF Aktiengesellschaft (DE) 1989-02-08 EP claimed